Literature DB >> 31718205

Measurement of body composition in cancer patients using CT planning scan at the third lumbar vertebra.

Bianca Tabita Muresan1, Carlos Sánchez Juan1, Ana Artero1, Ana Hernández Machancoses2, Piedad Almendros-Blanco2, Alegría Montoro3, Joan Roselló Ferrando4, Rafael Íñigo Valdenebro2, Jaime Ríos Ríos5, José Miguel Soriano Del Castillo6, José Vicente Quirante Cascales7, José López-Torrecilla2.   

Abstract

INTRODUCTION: Objective: the main objective was to assess body composition in terms of skeletal muscle index (SMI), myosteatosis, visceral adipose tissue (VAT), subcutaneous adipose tissue (SAT), and intermuscular adipose tissue (IMAT) as an adjunct of information provided by radiotherapy CT planning scan. Material and methods: a sample of 49 patients with lung and digestive cancers underwent a CT scan for radiotherapy treatment, which included measurements at the L3 region. Images were analyzed with a radiotherapy contouring software, using different Hounsfield Unit (HU) settings. Cross-sectional areas (cm2) were automatically computed by summing tissue pixels and multiplying by pixel surface area. Low SMI (cm2/m2) and muscle density (HU) were determined according to the recently established cut-off points.
Results: the prevalence of low SMI was detected in 46.94% of patients, being present in 8 women, 4 men with BMI < 25 kg/m2, and 11 men with BMI ≥ 25 kg/m2. The average mean skeletal attenuation of total skeletal muscle area was 29.02 (± 8.66) HU, and myosteatosis was present in 13 women (81.25%) and 31 men (93.94%). Mean SAT was 131.92 (± 76.80) cm2, mean VAT was 133.19 (± 85.28) cm2, and mean IMAT was 11.29 (± 12.86) cm2.
Conclusion: skeletal muscle abnormalities are frequently present in cancer patients and a low SMI may also exist even in the presence of overweight. As CT scans are an important tool at any radiation oncology department, they could also be used to offer highly sensitive and specific information about body composition, as well as to detect early malnutrition before starting radiotherapy treatment.

Entities:  

Keywords:  Cáncer. Radioterapia. Tomografía computarizada. Sarcopenia. Composición corporal.

Mesh:

Year:  2019        PMID: 31718205     DOI: 10.20960/nh.2435

Source DB:  PubMed          Journal:  Nutr Hosp        ISSN: 0212-1611            Impact factor:   1.057


  5 in total

1.  Cross-sectional analysis of myosteatosis and physical function in pretreatment head and neck cancer patients.

Authors:  Amy L Shaver; Katia Noyes; Mary E Platek; Anurag K Singh; Kayleigh Erickson; Elizabeth Wendel; Gregory Wilding; Heather M Ochs-Balcom; Andrew Ray
Journal:  Support Care Cancer       Date:  2022-01-08       Impact factor: 3.359

2.  Associations of intermuscular adipose tissue and total muscle wasting score in PG-SGA with low muscle radiodensity and mass in nonmetastatic colorectal cancer: A two-center cohort study.

Authors:  Yang Wang; Yuliuming Wang; Guodong Li; Hao Zhang; Hang Yu; Jun Xiang; Zitong Wang; Xia Jiang; Guoqing Yan; Yunxiao Liu; Chunlin Wang; Huan Xiong; Guiyu Wang; Hanping Shi; Ming Liu
Journal:  Front Nutr       Date:  2022-08-25

3.  Serum creatinine/cystatin C ratio is a systemic marker of sarcopenia in patients with gastrointestinal stromal tumours.

Authors:  Ping'an Ding; Honghai Guo; Chenyu Sun; Shuya Chen; Peigang Yang; Yuan Tian; Scott Lowe; Qun Zhao
Journal:  Front Nutr       Date:  2022-09-02

4.  Effect of skeletal muscle loss during neoadjuvant imatinib therapy on clinical outcomes in patients with locally advanced GIST.

Authors:  Ping'an Ding; Honghai Guo; Xiaoxiao He; Chenyu Sun; Scott Lowe; Rachel Bentley; Qin Zhou; Peigang Yang; Yuan Tian; Yang Liu; Li Yang; Qun Zhao
Journal:  BMC Gastroenterol       Date:  2022-08-26       Impact factor: 2.847

5.  Impact of Sarcopenia on Clinical Outcomes in a Cohort of Caucasian Active Crohn's Disease Patients Undergoing Multidetector CT-Enterography.

Authors:  Olga Maria Nardone; Andrea Ponsiglione; Roberto de Sire; Giulio Calabrese; Raffaele Liuzzi; Anna Testa; Alessia Dalila Guarino; Oriana Olmo; Antonio Rispo; Luigi Camera; Fabiana Castiglione
Journal:  Nutrients       Date:  2022-08-23       Impact factor: 6.706

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.